Back
ESC Premium Access

Genetic polymorphisms and cardiovascular outcomes in Chinese patients undergoing PCI and treated with clopidogrel and aspirin

Session: Pharmacology and Pharmacotherapy ePosters
Topic: Pharmacogenetics
Speaker: Doctor K. Xu (Shanghai, CN)
Event: ESC Congress 2020

Congress Presentation

Add to my library

Like

About the speaker

Doctor Ke Xu

Shanghai Chest Hospital, Shanghai (China)
0 follower

56 more presentations in this session

Tafolecimab, a novel potential long-acting PCSK9 monoclonal antibody: efficacy and safety in healthy and hypercholesterolemia subjects

Speaker: Professor Y. Huo (Beijing, CN)

Access
Abstract
Slides
Like
Thumbnail

Vericiguat clinical pharmacology programme: biopharmaceutical properties and potential intrinsic and extrinsic factor effects

Speaker: Doctor C. Becker (Wuppertal, DE)

Access
Abstract
Slides
Like
Thumbnail

Physiologically-based pharmacokinetic (PBPK) exploration of extrinsic factors influencing vericiguat pharmacokinetics

Speaker: Doctor S. Frechen (Leverkusen, DE)

Access
Abstract
Slides
Like
Thumbnail

Long-term safety and efficacy of bempedoic acid in patients at high risk of atherosclerotic cardiovascular disease: results from the CLEAR Harmony open-label extension study

Speaker: Doctor C. Ballantyne (Houston, US)

Access
Abstract
Slides
Like
Thumbnail

The effect of elevated triglycerides and purified eicosapentaenoic acid ethyl ester (EPA) for cardiovascular risk reduction in the UK Biobank population

Speaker: Doctor D. Radenkovic (Greater London, GB)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Pharmacology and Pharmacotherapy ePosters

Speakers: Doctor K. Xu, Professor Y. Huo, Doctor C. Becker, Doctor S. Frechen, Doctor C. Ballantyne...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources